Gilead's HIV, Liver Disease, and Oncology Portfolios Support a Wide Moat
We think its portfolio and pipeline support a wide moat, and with the HCV market stabilizing, Gilead needs strong continued innovation in HIV, solid oncology pipeline data, and smart future ...
4 Reasons to Buy This Index Fund and Hold for a Lifetime
A particularly convenient kind of index fund to invest in is an exchange-traded fund (ETF) -- a fund that trades like a stock ...
HQL: Attractive Valuation, Aligned To Benefit From Aging Gen X
Since abrdn's acquisition in 2023, HQL has delivered a total return of 25.5%, though its price appreciation has been modest.
Ideaya Biosciences: Potential Registration-Enabling Darovasertib Study Coming
Ideaya is financially strong, with $1.2 billion in cash reserves, sufficient to fund operations into at least 2028. Click ...
Business Wire2d
ASL Strategic Value Fund Letter to Avadel Pharmaceuticals (AVDL: NASDAQ) Board of Directors
The following is a letter that ASL Strategic Value Fund sent to the Board of Directors of Avadel Pharmaceuticals (NASDAQ:AVDL): Mr.